Seed VC · Italy
Claris Ventures makes equity investments in early stage biopharma companies with a clear vision and solid scientific evidence, committed to helping the best innovators address strong unmet clinical needs spanning rare diseases, oncology, immunology and other life-threatening disease areas.
Business models
biotech_therapeutics
Customer segments
Researchers, Healthcare providers
Geography
Europe
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Claris Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks Claris Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Claris Ventures is one of them — and we'll tell you exactly where they sit in your top 100.